Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses

Autor: Marinval, N., Morenc, M., Labour, M.N., Samotus, A., Mzyk, A., Ollivier, V., Maire, M., Jesse, K., Bassand, K., Niemiec-Cyganek, A., Haddad, O., Jacob, M.P., Chaubet, F., Charnaux, N., Wilczek, P., Hlawaty, H.

Publikováno v: In Biomaterials July 2018 172:14-29

miR-126-3p is essential for CXCL12-induced angiogenesis.

Autor: Bassand K; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Metzinger L; HEMATIM UR 4666, Centre Universitaire de Recherche en Santé (CURS), Université de Picardie Jules Verne, CHU-Amiens-Picardie, Amiens, France., Naïm M; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Mouhoubi N; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Haddad O; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Assoun V; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Zaïdi N; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Sainte-Catherine O; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Butt A; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Guyot E; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France.; Laboratoire de Biochimie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France., Oudar O; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Laguillier-Morizot C; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France.; Laboratoire de Biochimie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France., Sutton A; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France.; Laboratoire de Biochimie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France., Charnaux N; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France.; Laboratoire de Biochimie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France., Metzinger-Le Meuth V; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France., Hlawaty H; INSERM U1148, Laboratory for Vascular Translational Sciences (LVTS), UFR SMBH Université Sorbonne Paris Nord, Bobigny, France.

Publikováno v: Journal of cellular and molecular medicine [J Cell Mol Med] 2021 Jul; Vol. 25 (13), pp. 6032-6045. Date of Electronic Publication: 2021 Jun 12.

Polydopamine and gelatin coating for rapid endothelialization of vascular scaffolds.

Autor: Kopeć K; Warsaw University of Technology, Faculty of Chemical and Process Engineering, Division of Biotechnology and Bioprocess Engineering, BioMedical Engineering Laboratory, Waryńskiego 1, 00-645 Warsaw, Poland., Wojasiński M; Warsaw University of Technology, Faculty of Chemical and Process Engineering, Division of Biotechnology and Bioprocess Engineering, BioMedical Engineering Laboratory, Waryńskiego 1, 00-645 Warsaw, Poland., Eichler M; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany., Genç H; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany., Friedrich RP; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany., Stein R; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany., Singh R; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany., Alexiou C; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany., Hlawaty H; Laboratory for Vascular Translational Sciences, INSERM U1148, Groupe Biothérapies et Glycoconjugués, Université Sorbonne Paris Nord, UFR SMBH, Bobigny, France., Ciach T; Warsaw University of Technology, Faculty of Chemical and Process Engineering, Division of Biotechnology and Bioprocess Engineering, BioMedical Engineering Laboratory, Waryńskiego 1, 00-645 Warsaw, Poland; Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, Poleczki 19, 02-822 Warsaw, Poland. Electronic address: Tomasz.Ciach@pw.edu.pl., Cicha I; ENT-Department, Section of Experimental Oncology und Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Germany. Electronic address: Iwona.Cicha@uk-erlangen.de.

Publikováno v: Biomaterials advances [Biomater Adv] 2022 Mar; Vol. 134, pp. 112544. Date of Electronic Publication: 2021 Nov 14.

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy

Autor: Suffee, N., Le Visage, Catherine, Hlawaty, H., Aid-Launais, R., Vanneaux, V., Larghero, J., Haddad, O., Oudar, O., Charnaux, N., Sutton, Angela

Publikováno v: Scientific Reports
Scientific Reports, Nature Publishing Group, 2017, 7 (1), pp.13294. ⟨10.1038/s41598-017-13444-7⟩
Scientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)

International audience; Peripheral arterial disease results from the chronic obstruction of arteries leading to critical hindlimb ischemia. The aim was to develop a new therapeutic strategy of revascularization by using biodegradable and biocompatibl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::57a04836b6c354182c991308dc80638b
https://www.hal.inserm.fr/inserm-01844657/file/s41598-017-13444-7.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.